JP2010510495A5 - - Google Patents

Download PDF

Info

Publication number
JP2010510495A5
JP2010510495A5 JP2009537402A JP2009537402A JP2010510495A5 JP 2010510495 A5 JP2010510495 A5 JP 2010510495A5 JP 2009537402 A JP2009537402 A JP 2009537402A JP 2009537402 A JP2009537402 A JP 2009537402A JP 2010510495 A5 JP2010510495 A5 JP 2010510495A5
Authority
JP
Japan
Prior art keywords
determining
test mixture
individual
individual treatment
treatment according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009537402A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010510495A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/085033 external-priority patent/WO2008064138A2/en
Publication of JP2010510495A publication Critical patent/JP2010510495A/ja
Publication of JP2010510495A5 publication Critical patent/JP2010510495A5/ja
Pending legal-status Critical Current

Links

JP2009537402A 2006-11-17 2007-11-17 個別治療処置の方法 Pending JP2010510495A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85973906P 2006-11-17 2006-11-17
PCT/US2007/085033 WO2008064138A2 (en) 2006-11-17 2007-11-17 Personalized therapeutic treatment process

Publications (2)

Publication Number Publication Date
JP2010510495A JP2010510495A (ja) 2010-04-02
JP2010510495A5 true JP2010510495A5 (cg-RX-API-DMAC7.html) 2011-01-13

Family

ID=39430529

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009537402A Pending JP2010510495A (ja) 2006-11-17 2007-11-17 個別治療処置の方法

Country Status (7)

Country Link
EP (1) EP2094861A4 (cg-RX-API-DMAC7.html)
JP (1) JP2010510495A (cg-RX-API-DMAC7.html)
CN (1) CN101702921A (cg-RX-API-DMAC7.html)
AU (1) AU2007323782A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0719314A2 (cg-RX-API-DMAC7.html)
CA (1) CA2669864A1 (cg-RX-API-DMAC7.html)
WO (1) WO2008064138A2 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0714040D0 (en) * 2007-07-19 2007-08-29 Xceleron Ltd Quantification of analytes
CN105467108A (zh) * 2015-12-19 2016-04-06 开滦总医院 溶栓药物个体化应用剂量的体外测定试验方法
US20200116657A1 (en) * 2018-10-15 2020-04-16 Olaris, Inc. Nmr-metabolite-signature for identifying cancer patients resistant to cdk4/6 inhibitors, endocrine therapy and anti-her2 therapy
US20220367023A1 (en) * 2019-10-18 2022-11-17 National University Of Singapore Method for Predicting a Suitable Therapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4131544A (en) * 1976-08-03 1978-12-26 Nasik Elahi Macroencapsulated sorbent element and process for using the same
US4880014A (en) * 1987-08-14 1989-11-14 Zarowitz Barbara J Method for determining therapeutic drug dosage using bioelectrical resistance and reactance measurements
GB0304433D0 (en) * 2003-02-27 2003-04-02 Xceleron Ltd Improvements relating to chemical libraries
US20060228694A1 (en) * 2003-04-02 2006-10-12 Janoff Andrew S Methods to individualize combination therapy
CA2581127C (en) * 2004-09-20 2013-12-24 Resonant Medical Inc. Radiotherapy treatment monitoring using ultrasound
JP5529379B2 (ja) * 2004-10-28 2014-06-25 リザーランド，アルバート，エドワード 同重体干渉物を分離する方法および機器
GB0504243D0 (en) * 2005-03-02 2005-04-06 Xceleron Ltd Biological compositions labelled with radioisotope

Similar Documents

Publication Publication Date Title
Walker et al. Leucine competes with kynurenine for blood-to-brain transport and prevents lipopolysaccharide-induced depression-like behavior in mice
Kadriu et al. Glutamatergic neurotransmission: pathway to developing novel rapid-acting antidepressant treatments
Cai et al. Therapeutic effect of fecal microbiota transplantation on chronic unpredictable mild stress-induced depression
Haroon et al. Inflammation effects on brain glutamate in depression: mechanistic considerations and treatment implications
Ghebremariam et al. Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis
Kirschneck et al. Regular nicotine intake increased tooth movement velocity, osteoclastogenesis and orthodontically induced dental root resorptions in a rat model
JP2016513640A5 (cg-RX-API-DMAC7.html)
WO2009021521A3 (en) Use of gaboxadol for the manufacture of a medicament for treating stress-mediated depression
JP2013520681A5 (cg-RX-API-DMAC7.html)
JP2010540657A5 (cg-RX-API-DMAC7.html)
JP2017519006A5 (cg-RX-API-DMAC7.html)
Spurney et al. CINRG pilot trial of coenzyme Q10 in steroid‐treated duchenne muscular dystrophy
JP2010510495A5 (cg-RX-API-DMAC7.html)
Troutman et al. Skeletal muscle complications in chronic kidney disease
Zhang et al. Involvement of kynurenine metabolism in bipolar disorder: an updated review
CN105031212B (zh) 一种治疗帕金森病的药物
Steiner et al. Luteal phase administration of paroxetine for the treatment of premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled trial in Canadian women.
Arena et al. Effects of aerobic exercise on oxidative stress in patients diagnosed with cancer: a narrative review
Xu et al. Zhisou powder suppresses airway inflammation in LPS and CS-induced post-infectious cough model mice via TRPA1/TRPV1 channels
Yang et al. The dose limits of teeth protection for patients with nasopharyngeal carcinoma undergoing radiotherapy based on the early oral health-related quality of life
Nord Levodopa pharmacokinetics-from stomach to brain: A study on patients with Parkinson’s disease
CN102789550A (zh) 一种利用跨物种相似性的元分析方法
Stefaniak et al. In the search for the treatment of compensatory sweating
Liang et al. The antihypertensive felodipine shows synergistic activity with immune checkpoint blockade and inhibits tumor growth via NFAT1 in LUSC
Wei et al. Altered gut microbial profiles in drug-treated rats with alcoholic heart disease